We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS CALL SAMPLE RECOMMENDATIONS IN GUIDANCE EXCESSIVE
DRUGMAKERS CALL SAMPLE RECOMMENDATIONS IN GUIDANCE EXCESSIVE
March 19, 2004
The number of samples recommended by the FDA for testing in-process dosage units during tablet manufacturing is too high and would likely place a burden on firms, drugmakers told the agency in comments released last week on its powder blend uniformity draft guidance.